New combo targets tough breast cancer in early trial
NCT ID NCT04253561
First seen Mar 24, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This early-phase study tested a new combination of drugs for people with a specific type of advanced breast cancer (HER2-positive with a PIK3CA mutation). The goal was to find the safest dose of the new drug (ipatasertib) when added to two standard treatments. Only 17 people took part, and the focus was on safety and finding the right dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Integral Oncológico Clara Campal (CIOCC)
Madrid, Madrid, Spain
-
Comp. Hosp.Univ. Santiago (Chus)
Santiago de Compostela, La Coruña, Spain
-
Fundación Instituto Valenciano de Oncología
Valencia, Valencia, Spain
-
H.Univ. Arnau de Vilanova de Lleida
Lleida, Lleida, Spain
-
Hospital Universitario Doce de Octubre
Madrid, Madrid, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Sevilla, Spain
-
Hospital Universitario del Vall d' Hebron
Barcelona, Barcelona, Spain
-
Hospital Virgen de Macarena
Seville, Sevilla, Spain
-
ICO Badalona
Badalona, Barcelona, Spain
-
MD Anderson
Madrid, Madrid, Spain
Conditions
Explore the condition pages connected to this study.